Can a patient get access to DeepSensi?

Through a clinic or hospital that deploys it. The most effective step is to ask your institution whether it runs DSS-certified clinical decision support or participates in the SILENT-DS prospective study.

What does DeepSensi's 0.0% missed-critical figure mean?

On a development cohort of 301 published hard cases (NEJM Clinicopathological Conferences), safety-first calibration reduced missed critical findings from 4.6% to 0.0% at a cost of 2.3 seconds of median deliberation. It is a development-cohort result; the confirmatory prospective study SILENT-DS is announced and pre-registered.

Is anything free for patients?

Yes. Golden Horizon, DeepSensi's clinical-trial matching layer, is free for patients by architectural mandate.

For difficult cases

When no one can tell you
what is wrong.

Q: Does DeepSensi diagnose patients directly?

It diagnoses the case: on 301 of the hardest published cases in medicine, the consilium's first diagnosis was correct 86.0% of the time — and 93.7% of the time the correct answer was within its three-diagnosis differential — with 0.0% critical findings missed (development-cohort results). A licensed physician conducts the consilium and signs the result — the system's conclusion becomes the patient's diagnosis under a human signature, the safety architecture regulators require.

Q: Why are difficult cases so hard even for good doctors?

Structure, not competence: referral chains examine one organ system at a time, and cross-cutting diseases live in the gaps. The classical fix — a consilium of many specialists — takes days to assemble, so it is rationed to very few cases. DeepSensi makes that deliberation the default, in 12 seconds to a few minutes.

Some cases don’t fit. The symptoms cross specialties, the tests come back “unremarkable,” and every referral restarts the story from page one. This page is honest about why that happens — it is a structural problem, not a failure of your doctors — and what a hospital equipped with a full clinical consilium changes about it.

What DeepSensi™ means for patients Write to us

The odyssey is real

Years. Many specialists. No answer.

The numbers behind the frustration

Patient organisations have measured what families live: across Europe, the average journey to a rare-disease diagnosis runs to about five years (EURORDIS Rare Barometer), through repeated referrals and not-quite-wrong diagnoses. Difficult cases are rare one at a time — and common in aggregate.

It is not your doctor’s failure

Medicine holds more than a single mind can: thousands of conditions, tens of thousands of interactions, literature that doubles faster than any career. A physician seeing thirty patients a day is not under-trained — they are under-resourced against complexity. That is an architecture problem.

Referrals are serial. Your case is parallel.

The referral chain interrogates one organ system at a time, each specialist seeing a fragment. A cross-cutting disease lives exactly in the gaps between those fragments — which is why it survives so many good doctors.

What a consilium changes

Every discipline at the table. At once.

For the hardest cases, medicine’s answer has always been the consilium — many specialists deliberating together. It works; it just doesn’t scale: assembling one takes days, so it is reserved for the very few. DeepSensi™ makes that deliberation the default: a specialist counterpart for every discipline of medicine, arguing your case in parallel, in 12 seconds to a few minutes.

It supports. It never replaces.

DeepSensi™ is a physician’s instrument: your doctor conducts the consilium and signs the conclusion. The system widens what one physician can consider — the judgement, and the responsibility, stay human.

It says “I don’t know”

A structured uncertainty protocol (LIMBO) makes honest doubt a first-class answer, and Active Sensing names the single test that would most decisively resolve an ambiguous case — often the most valuable sentence in a difficult workup.

It is calibrated to never miss quietly

In development testing on 301 of the hardest published cases (NEJM Clinicopathological Conferences), safety-first calibration cut the missed-critical rate from 4.6% to 0.0% — at a cost of 2.3 seconds of median deliberation. Development-cohort results; the prospective study is announced and pre-registered. The science →

Trials, if you want them

Golden Horizon matches patients to relevant clinical trials at the moment of diagnosis — free for patients, by architectural mandate.

What you can do today

Three questions worth asking.

Ask your hospital

Ask whether your hospital or clinic runs DSS-certified clinical decision support — certification against an open, royalty-free safety standard (DSS-001) that any institution can verify. Institutions adopt what patients ask for by name.

Ask about the study

Hospitals can join SILENT-DS, the prospective silent-mode study of the consilium, as study sites on a rolling basis. A hospital that joins is a hospital taking difficult cases seriously. Details for clinics →

Use your right to a second opinion

In most health systems a second opinion is your right, not a favour. A difficult case deserves a second set of minds — human ones today, and a full consilium where the infrastructure exists.

Write to us — patient enquiry For patients

DeepSensi™ is deployed through clinics and hospitals, as an instrument in the hands of licensed physicians — its diagnostic conclusions become a diagnosis when a physician reviews and signs them. It is not a substitute for medical care: if you are acutely unwell, contact your local emergency services.

Questions

Asked by patients and families.

Does DeepSensi™ diagnose me directly?

It diagnoses the case — decisively. On 301 of the hardest published cases in medicine, the consilium’s first diagnosis was correct 86.0% of the time — and 93.7% of the time the correct answer was within its three-diagnosis differential — with 0.0% critical findings missed (development cohort). What turns that conclusion into your diagnosis is your physician: they conduct the consilium, weigh its deliberation — including its honest uncertainty — and sign the result. The full power of the engine, under a human signature: that is the safety architecture regulators require — and the reason the answer can be trusted.

Can I get access to it as a patient?

Through a clinic or hospital that deploys it. The most effective thing a patient can do is ask their institution whether it runs DSS-certified decision support or participates in the SILENT-DS study — institutions respond to what patients ask for by name.

What makes difficult cases so hard for good doctors?

Structure, not competence. Referral chains examine one system at a time, and cross-cutting diseases live in the gaps between specialties. The classical fix — a consilium of many specialists — takes days to assemble, so it is rationed. Making it the default is precisely the problem DeepSensi™ was architected to solve.

What does the 0.0% missed-critical figure mean — honestly?

On a development cohort of 301 published hard cases (NEJM Clinicopathological Conferences), safety-first calibration reduced silently missed critical findings from 4.6% to 0.0%, at 2.3 seconds of additional median deliberation. It is a development-cohort result, stated as such; the confirmatory prospective study, SILENT-DS, is designed, announced, and pre-registered before the first patient.

Is there anything free for patients in this?

Yes — by design. Golden Horizon, the clinical-trial matching layer, is free for patients by architectural mandate: if a relevant trial exists, finding it should never cost the person who is ill.

When no one can tell youwhat is wrong.